Cargando…
Fulminant Giant Cell Myocarditis and Cardiogenic Shock: An Unusual Presentation of Malignant Thymoma
Malignant thymoma is rarely associated with giant cell myocarditis. We present a case study that illustrates this association and cardiogenic shock with underlying tamponade. The dramatic presentation of this scenario has not been previously described.
Autores principales: | Koul, Deepak, Kanwar, Manreet, Jefic, Dane, Kolluru, Anuradha, Singh, Tejwant, Dhar, Sunil, Kumar, Preetham, Cohen, Gerald |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864446/ https://www.ncbi.nlm.nih.gov/pubmed/20454573 http://dx.doi.org/10.4061/2010/185896 |
Ejemplares similares
-
Immune-Checkpoint Inhibitor-Induced Fulminant Myocarditis and Cardiogenic Shock
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2019) -
Giant Cell Myocarditis: Not Always a Presentation of Cardiogenic Shock
por: Tompkins, Rose, et al.
Publicado: (2015) -
Elasomeran: Acute fulminant lymphocytic myocarditis and cardiogenic shock: case report
Publicado: (2022) -
An Undetected Pheochromocytoma Leading to Fulminant Adrenergic Myocarditis Complicated by Cardiogenic Shock
por: Tran, Nam Q, et al.
Publicado: (2023) -
Fulminant myocarditis and cardiogenic shock during SARS-CoV-2 infection()
por: Lozano Gómez, Herminia, et al.
Publicado: (2020)